Jaguar Health Inc (NASDAQ:JAGX) shares rose 8.3% during trading on Friday . The company traded as high as $0.17 and last traded at $0.13. Approximately 14,107,399 shares were traded during trading, an increase of 1,000% from the average daily volume of 1,282,640 shares. The stock had previously closed at $0.12.

The company has a debt-to-equity ratio of 0.35, a current ratio of 0.26 and a quick ratio of 0.15.

WARNING: “Jaguar Health (JAGX) Stock Price Up 8.3%” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at

About Jaguar Health

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with's FREE daily email newsletter.